Literature DB >> 27156070

The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines.

Ismael Riquelme1,2, Oscar Tapia1, Jaime A Espinoza3,4,5, Pamela Leal6, Kurt Buchegger1,2, Alejandra Sandoval4,5, Carolina Bizama3,4,5, Juan Carlos Araya7, Richard M Peek8, Juan Carlos Roa9,10,11.   

Abstract

The PI3K/AKT/mTOR pathway plays a crucial role in the regulation of multiple cellular functions including cell growth, proliferation, metabolism and angiogenesis. Emerging evidence has shown that deregulation of this pathway has a role promoting gastric cancer (GC). The aim was to assess the expression of genes involved in this pathway by qPCR in 23 tumor and 23 non-tumor gastric mucosa samples from advanced GC patients, and in AGS, MKN28 and MKN45 gastric cancer cell lines. Results showed a slight overexpression of PIK3CA, PIK3CB, AKT1, MTOR, RPS6KB1, EIF4EBP1 and EIF4E genes, and a slightly decreased PTEN and TSC1 expression. In AGS, MKN28 and MKN45 cells a significant gene overexpression of PIK3CA, PIK3CB, AKT1, MTOR, RPS6KB1 and EIF4E, and a significant repression of PTEN gene expression were observed. Immunoblotting showed that PI3K-β, AKT, p-AKT, PTEN, mTOR, p-mTOR, P70S6K1, p-P70S6K1, 4E-BP1, p-4E-BP1, eIF4E and p-eIF4E proteins were present in cell lines at different levels, confirming activation of this pathway in vitro. This is the first time this extensive panel of 9 genes within PI3K/AKT/mTOR pathway has been studied in GC to clarify the biological role of this pathway in GC and develop new strategies for this malignancy.

Entities:  

Keywords:  AGS, MKN28 and MKN45 cell lines; Gastric cancer; PI3K/AKT/mTOR pathway

Mesh:

Substances:

Year:  2016        PMID: 27156070      PMCID: PMC5890336          DOI: 10.1007/s12253-016-0066-5

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  34 in total

1.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

Review 2.  Targeting the RTK-PI3K-mTOR axis in malignant glioma: overcoming resistance.

Authors:  Qi-Wen Fan; William A Weiss
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 3.  Upstream and downstream of mTOR.

Authors:  Nissim Hay; Nahum Sonenberg
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

Review 4.  Targeted therapy for gastric cancer: molecular pathways and ongoing investigations.

Authors:  Wei Yang; Alexander Raufi; Samuel J Klempner
Journal:  Biochim Biophys Acta       Date:  2014-05-22

5.  Expression of PI3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis.

Authors:  B Ye; L-L Jiang; H-T Xu; D-W Zhou; Z-S Li
Journal:  Int J Immunopathol Pharmacol       Date:  2012 Jul-Sep       Impact factor: 3.219

Review 6.  mTOR as a therapeutic target in patients with gastric cancer.

Authors:  Salah-Eddin Al-Batran; Michel Ducreux; Atsushi Ohtsu
Journal:  Int J Cancer       Date:  2011-10-05       Impact factor: 7.396

7.  Upregulation of the eIF4E signaling pathway contributes to the progression of gastric cancer, and targeting eIF4E by perifosine inhibits cell growth.

Authors:  Song Liang; Renhua Guo; Zhihong Zhang; Dongxiao Liu; Hao Xu; Zekuan Xu; Xuerong Wang; Li Yang
Journal:  Oncol Rep       Date:  2013-04-09       Impact factor: 3.906

8.  Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues.

Authors:  Songqing Fan; Suresh S Ramalingam; John Kauh; Zhiheng Xu; Fadlo R Khuri; Shi-Yong Sun
Journal:  Cancer Biol Ther       Date:  2009-08-08       Impact factor: 4.742

9.  Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation.

Authors:  Dan-feng Sun; Yan-jie Zhang; Xiao-qing Tian; Ying-xuan Chen; Jing-yuan Fang
Journal:  Cell Biol Int       Date:  2013-10-10       Impact factor: 3.612

Review 10.  A comprehensive map of the mTOR signaling network.

Authors:  Etienne Caron; Samik Ghosh; Yukiko Matsuoka; Dariel Ashton-Beaucage; Marc Therrien; Sébastien Lemieux; Claude Perreault; Philippe P Roux; Hiroaki Kitano
Journal:  Mol Syst Biol       Date:  2010-12-21       Impact factor: 11.429

View more
  31 in total

1.  Hypoxic Macrophage-Derived VEGF Promotes Proliferation and Invasion of Gastric Cancer Cells.

Authors:  Fei Ma; Bin Zhang; Sheqing Ji; Hongtao Hu; Ye Kong; Yawei Hua; Suxia Luo
Journal:  Dig Dis Sci       Date:  2019-05-17       Impact factor: 3.199

Review 2.  RETRACTED ARTICLE: Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours.

Authors:  Fei Xu; Lixin Na; Yanfei Li; Linjun Chen
Journal:  Cell Biosci       Date:  2020-04-01       Impact factor: 7.133

3.  Thymoquinone induces cytotoxicity and reprogramming of EMT in gastric cancer cells by targeting PI3K/Akt/mTOR pathway.

Authors:  Li-Min Feng; Xue-Feng Wang; Qing-Xian Huang
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

4.  Anticancer effect of resibufogenin on gastric carcinoma cells through the phosphoinositide 3-kinase/protein kinase B/glycogen synthase kinase 3β signaling pathway.

Authors:  Zhen Lu; Aman Xu; Xiao Yuan; Kaiwei Chen; Likun Wang; Tao Guo
Journal:  Oncol Lett       Date:  2018-06-18       Impact factor: 2.967

Review 5.  Gastric cancer: a comprehensive review of current and future treatment strategies.

Authors:  Rachel E Sexton; Mohammed Najeeb Al Hallak; Maria Diab; Asfar S Azmi
Journal:  Cancer Metastasis Rev       Date:  2020-09-07       Impact factor: 9.264

6.  Valproic acid induces autophagy by suppressing the Akt/mTOR pathway in human prostate cancer cells.

Authors:  Qinghua Xia; Yi Zheng; Wei Jiang; Zhongxian Huang; Muwen Wang; Ronald Rodriguez; Xunbo Jin
Journal:  Oncol Lett       Date:  2016-07-18       Impact factor: 2.967

7.  Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.

Authors:  Guo-Dong Cao; Xing-Yu Xu; Jia-Wei Zhang; Bo Chen; Mao-Ming Xiong
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

8.  Long non-coding RNA GASL1 restrains gastric carcinoma cell proliferation and metastasis by sponging microRNA-106a.

Authors:  Dengqiang Liu; Peng Xiao; Chao Feng; Hui Meng; Enxu Bi
Journal:  Cell Cycle       Date:  2020-09-08       Impact factor: 4.534

9.  QPCT regulation by CTCF leads to sunitinib resistance in renal cell carcinoma by promoting angiogenesis.

Authors:  Tangliang Zhao; Yulin Zhou; Qingyun Wang; Xiaoming Yi; Silun Ge; Haowei He; Song Xue; Bowen Du; Jingping Ge; Jie Dong; Le Qu; Linhui Wang; Wenquan Zhou
Journal:  Int J Oncol       Date:  2021-05-26       Impact factor: 5.650

10.  Associations of individual and joint expressions of ERCC6 and ERCC8 with clinicopathological parameters and prognosis of gastric cancer.

Authors:  Jing Chen; Liang Li; Liping Sun; Yuan Yuan; Jingjing Jing
Journal:  PeerJ       Date:  2021-07-15       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.